Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSHR | P16473 | 1/20 | 0.47 |
| ▸ | HTR6 | P50406 | 2/20 | 0.39 |
| ▸ | APP | P05067 | 3/20 | 0.35 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.33 |
| ▸ | RECQL | P46063 | 2/20 | 0.33 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.33 |
| ▸ | CA12 | O43570 | 1/20 | 0.33 |
| ▸ | CA1 | P00915 | 1/20 | 0.33 |
| ▸ | CA2 | P00918 | 1/20 | 0.33 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.33 |
| ▸ | TP53 | P04637 | 1/20 | 0.33 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.33 |
| ▸ | THRB | P10828 | 1/20 | 0.33 |
| ▸ | HPGD | P15428 | 1/20 | 0.33 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.33 |
| ▸ | CASP1 | P29466 | 1/20 | 0.33 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.33 |
| ▸ | KIF11 | P52732 | 1/20 | 0.32 |
| ▸ | ADRA2A | P08913 | 1/20 | 0.32 |
| ▸ | ADRA2B | P18089 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Iodide SCHEMBL31463955 | 0.96 | TSHR (0.44) | TSHRHTR6APPALDH1A1RECQL | |
| SCHEMBL13198271 | 0.86 | RAPGEF4 (0.42) | TSHRHTR6ALDH1A1CYP3A4THRB | |
| SCHEMBL12990555 | 0.83 | HTR6 (0.47) | TSHRHTR6ALDH1A1CA12CA1 | |
| SCHEMBL22852016 | 0.83 | TSHR (0.36) | TSHRHTR6ADRA2AADRA2BADRA2C | |
| SCHEMBL3783747 | 0.83 | TSHR (0.41) | TSHRHTR6ALDH1A1MAPT | |
| SCHEMBL5506973 | 0.83 | RAPGEF4 (0.39) | TSHRHTR6APPCA12CA1 | |
| SCHEMBL19709350 | 0.83 | TSHR (0.36) | TSHRHTR6ADRA2AADRA2BADRA2C | |
| SCHEMBL20763402 | 0.78 | TDP1 (0.46) | TSHRHTR6ALDH1A1RECQLHSD17B10 | |
| SCHEMBL19844318 | 0.78 | PTGS2 (0.36) | TSHRHTR6ALDH1A1HSD17B10TP53 | |
| SCHEMBL20082558 | 0.78 | GABRA1 (0.42) | TSHRHTR6ALDH1A1HSD17B10KDM4E |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 26 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-119816088-A | Perovskite passivation material, passivation layer film, preparation method of perovskite passivation material and passivation layer film, and perovskite solar cell | 中国华能集团清洁能源技术研究院有限公司 | 2025-04-11 | — | — | CN | disclosed |
| US-11078413-B2 | Organic-inorganic hybrid perovskites, devices, and methods | FLORIDA STATE UNIVERSITY RESEARCH FOUNDATION, INC. (US) | 2021-08-03 | — | — | US | disclosed |
| US-20210032273-A1 | Methods of Making Metal Halide Perovskites | FLORIDA STATE UNIVERSITY RESEARCH FOUNDATION, INC. | 2021-02-04 | — | — | US | disclosed |
| WO-2020165600-A1 | BICYCLIC PEPTIDE LIGAND STING CONJUGATES AND USES THEREOF | BICYCLETX LIMITED (GB) | 2020-08-20 | — | — | WO | disclosed |
| CN-108807939-A | Preparation method of azo porous material/carbon nano tube composite electrode material | 盐城师范学院 | 2018-11-13 | — | — | CN | disclosed |
| CN-108751163-A | A kind of preparation method of nitrogen-doped porous carbon material | 盐城师范学院 | 2018-11-06 | — | — | CN | disclosed |
| US-10059666-B2 | Oxygen scavengers, compositions comprising the scavengers, and articles made from the compositions | PLASTIPAK PACKAGING, INC. (US) | 2018-08-28 | — | — | US | disclosed |
| EP-2499134-B1 | OXYGEN SCAVENGERS, COMPOSITION COMPRISING THE SCAVENGERS, AND ARTICLES MADE FROM THE COMPOSITIONS | PLASTIPAK PACKAGING INC (US) | 2018-04-18 | — | — | EP | disclosed |
| US-9896462-B1 | Metal halide perovskites, methods, and devices | FLORIDA STATE UNIVERSITY RESEARCH FOUNDATION, INC. (US) | 2018-02-20 | — | — | US | disclosed |
| US-20180037813-A1 | Organic-Inorganic Hybrid Perovskites, Devices, and Methods | FLORIDA STATE UNIVERSITY RESEARCH FOUNDATION, INC. | 2018-02-08 | — | — | US | disclosed |
| US-8450398-B2 | Oxygen scavengers, compositions comprising the scavengers, and articles made from the compositions | CONSTAR INTERNATIONAL, INC. (US) | 2013-05-28 | — | — | US | disclosed |
| EP-2499134-A2 | OXYGEN SCAVENGERS, COMPOSITION COMPRISING THE SCAVENGERS, AND ARTICLES MADE FROM THE COMPOSITIONS | Constar International Inc. (US) | 2012-09-19 | — | — | EP | disclosed |
| US-20120152822-A1 | POLYMERIC MATRICES FORMED FROM MONOMERS COMPRISING A PROTECTED AMINE GROUP | BL TECHNOLOGIES, INC. | 2012-06-21 | — | — | US | disclosed |
| CN-102414215-A | Structured organic films having an added functionality | XEROX CORP | 2012-04-11 | — | — | CN | disclosed |
| US-8034952-B2 | Supramolecular assemblies and building blocks | UNIVERSITY OF SOUTH FLORIDA (US) | 2011-10-11 | — | — | US | disclosed |
| WO-2011060297-A2 | OXYGEN SCAVENGERS, COMPOSITION COMPRISING THE SCAVENGERS, AND ARTICLES MADE FROM THE COMPOSITIONS | CONSTAR INTERNATIONAL, INC. (US) | 2011-05-19 | — | — | WO | disclosed |
| US-20110117301-A1 | OXYGEN SCAVENGERS, COMPOSITIONS COMPRISING THE SCAVENGERS, AND ARTICLES MADE FROM THE COMPOSITIONS | WELLS FARGO BANK, N.A., AS ADMINISTRATIVE AGENT | 2011-05-19 | — | — | US | disclosed |
| US-20100183598-A1 | METHODS OF TREATING CARDIOVASCULAR DISORDERS | CAROLUS THERAPEUTICS, INC. (US) | 2010-07-22 | — | — | US | disclosed |
| US-20090143596-A1 | Supramolecular Assemblies and Building Blocks | UNIVERSITY OF SOUTH FLORIDA (US) | 2009-06-04 | — | — | US | disclosed |
| CN-101384610-A | 11 beta-hydroxyandrostan-4-en-3-ones | SUN PHARMA ADVANCED RES CO LTD (IN) | 2009-03-11 | — | — | CN | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (7 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20180037813-A1 | Organic-Inorganic Hybrid Perovskites, Devices, and Methods | TYR, HCN4, BMI1 | TSHR 2345/4885HTR6 3091/4885APP 1945/4885 |
| US-20210032273-A1 | Methods of Making Metal Halide Perovskites | SOD1, HCN4, KCND2 | TSHR 3434/4885HTR6 2527/4885APP 2309/4885 |
| US-11078413-B2 | Organic-inorganic hybrid perovskites, devices, and methods | TYR, HCN4, BMI1 | TSHR 2345/4885HTR6 3091/4885APP 1945/4885 |
| US-10059666-B2 | Oxygen scavengers, compositions comprising the scavengers, and articles made from the compositions | PRDX5, LPO, CAT | TSHR 3903/4885HTR6 4332/4885APP 2080/4885 |
| US-20110117301-A1 | OXYGEN SCAVENGERS, COMPOSITIONS COMPRISING THE SCAVENGERS, AND ARTICLES MADE FROM THE COMPOSITIONS | PRDX5, LPO, CAT | TSHR 3903/4885HTR6 4332/4885APP 2080/4885 |
| US-20090143596-A1 | Supramolecular Assemblies and Building Blocks | TERB1, TBCB, PARG | TSHR 3936/4885HTR6 4319/4885APP 1058/4885 |
| US-20100183598-A1 | METHODS OF TREATING CARDIOVASCULAR DISORDERS | TNNI3, TNNT2, FABP3 | TSHR 4222/4885HTR6 56/4885APP 1350/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.